TRV GP V, LLC — SEC Form 4 filings
SEC reporting owner CIK 1990717. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-10 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 3 filings — 1,709,203 shares, $17,980,525 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 5 filings — 1,001,908 shares, $41,791,084 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 426,005 shares @ $40.32 ($17,175,244) in Rapport Therapeutics, Inc., filed 2026-04-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | 10% owner | 5 | — | 5 legs · 854,708 sh · $34,391,226 | 5 |
| Septerna, Inc. (SEPN) | 10% owner | 4 | 5 legs · 1,709,203 sh · $17,980,525 | 2 legs · 147,200 sh · $7,399,858 | 4 |
| Maze Therapeutics, Inc. (MAZE) | 10% owner | 2 | — | — | 6 |
Form 4 filings — TRV GP V, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Septerna, Inc. (SEPN) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Sale (S): 147,059 @ $50.27 · Sale (S): 141 @ $51.08 | EDGAR |
| 2026-05-28 | 4 | Rapport Therapeutics, Inc. (RAPP) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Sale (S): 18,572 @ $40.05 | EDGAR |
| 2026-05-13 | 4 | Rapport Therapeutics, Inc. (RAPP) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Sale (S): 133,618 @ $40.24 | EDGAR |
| 2026-05-11 | 4 | Rapport Therapeutics, Inc. (RAPP) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Sale (S): 271,495 @ $40.12 · Sale (S): 5,018 @ $40.31 | EDGAR |
| 2026-04-21 | 4 | Rapport Therapeutics, Inc. (RAPP) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Sale (S): 426,005 @ $40.32 | EDGAR |
| 2025-11-05 | 4 | Maze Therapeutics, Inc. (MAZE) jointly with Third Rock Ventures IV, L.P., Third Rock Ventures GP IV, L.P., TRV GP IV, LLC, Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP | Other (J): 1,600,000 | EDGAR |
| 2025-02-26 | 4 | Septerna, Inc. (SEPN) jointly with Third Rock Ventures VI, L.P., Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Purchase (P): 18,861 @ $6.00 | EDGAR |
| 2025-02-24 | 4 | Septerna, Inc. (SEPN) jointly with Third Rock Ventures VI, L.P., Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Purchase (P): 612,674 @ $5.92 · Purchase (P): 427,668 @ $5.94 | EDGAR |
| 2025-02-04 | 4 | Maze Therapeutics, Inc. (MAZE) jointly with Third Rock Ventures IV, L.P., Third Rock Ventures GP IV, L.P., TRV GP IV, LLC, Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP | Conversion (C): 5,762,788 @ $0 · Conversion (C): 950,800 @ $0 · Conversion (C): 45,833,334 (derivative) @ $0 · Conversion (C): 9,725,709 (derivative) @ $0 · Conversion (C): 9,166,666 (derivative) @ $0 | EDGAR |
| 2024-10-28 | 4 | Septerna, Inc. (SEPN) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Conversion (C): 4,790,773 @ $0 · Conversion (C): 2,872,956 @ $0 · Purchase (P): 370,500 @ $18 · Purchase (P): 279,500 @ $18 · Conversion (C): 41,250,000 (derivative) @ $0 · Conversion (C): 24,737,017 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) jointly with Third Rock Ventures V, L.P., Third Rock Ventures GP V, LP, Third Rock Ventures VI, L.P., Third Rock Ventures GP VI, L.P., TRV GP VI, LLC | Conversion (C): 6,551,449 @ $0 · Conversion (C): 969,218 @ $0 · Conversion (C): 56,091,177 (derivative) @ $0 · Conversion (C): 8,000,000 (derivative) @ $0 · Conversion (C): 298,103 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1990717 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →